Most Recent Additions*

Link

Pediatric Dermatology Learning Needs Identified Through Continuing Certification Program Assessments of the American Board of Dermatology.
Erik J Stratman, Julie V Schaffer, Stanley J Miller, Anna L Bruckner, Mercedes E Gonzalez, Andrea L Zaenglein, and Randall K Roenigk

Link

Chromatin Disruption After Prenatal Hypoxia Predicts Lasting Neuron Deficits.
Ana G Cristancho, Donald J Joseph, Margaret M Cassidy, Preeti S Chauhan, Ethan J Gadra, Elyse C Gadra, Donya Zarrinnegar, Bianca N Rodriguez, and Eric D Marsh

Link

Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.
Jonathan I Silverberg, Emma Guttman-Yassky, Diamant Thaçi, Alan D Irvine, Linda Stein Gold, Andrew Blauvelt, Eric L Simpson, Chia-Yu Chu, Zhuqing Liu, Renata Gontijo Lima, Sreekumar G Pillai, Julien Seneschal, ADvocate1 and ADvocate2 Investigators, and Stephen Schleicher MD

Link

Lack of effect of benralizumab on signs and symptoms of moderate-to-severe atopic dermatitis: Results from the phase 2 randomized, double-blind, placebo-controlled HILLIER trial.
E Guttman-Yassky, L Bahadori, L Brooks, K L Clark, H Grindebacke, C N Ho, R Katial, T-H Pham, C Walton, C J Datto, HILLIER study group, and Stephen Schleicher MD

Link

Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.
Christopher E M Griffiths, Kristian Reich, Mark Lebwohl, Peter van de Kerkhof, Carle Paul, Alan Menter, Gregory S Cameron, Janelle Erickson, Lu Zhang, Roberta J Secrest, Susan Ball, Daniel K Braun, Olawale O Osuntokun, Michael P Heffernan, Brian J Nickoloff, Kim Papp, UNCOVER-2 and UNCOVER-3 investigators, and Stephen Schleicher MD

Link

Adapalene 0.1% lotion in the treatment of acne vulgaris: results from two placebo-controlled, multicenter, randomized double-blind, clinical studies.
Lawrence F Eichenfield, Michael Jarratt, Joel Schlessinger, Steven Kempers, Vasant Manna, Joyce Hwa, Yin Liu, Michael Graeber, Adapalene Lotion Study Group, and Stephen Schleicher MD

*Updated as of 12/17/25.